FDA Approves First Treatment for Ebola Virus

Submitted by [email protected] on Wed, 10/14/2020 - 12:00 PM


On October 14, 2020 the U.S. Food and Drug Administration (FDA) approved Inmazeb an antibody mixture consisting of atoltivimab, maftivimab, and odesivimab-ebgn. This is the FDA's first approved treatment for the Ebola virus. 

Content Source: Press Release

Content Author: US Food and Drug Administration